Combined gene therapy of vascular endothelial growth factor and apelin for a chronic cerebral hypoperfusion model in rats

OBJECT: The aim of this study is to evaluate whether the combined gene therapy of vascular endothelial growth factor (VEGF) and apelin in indirect vasoreconstructive surgery enhances brain angiogenesis in a chronic cerebral hypoperfusion model in rats. METHODS: A chronic cerebral hypoperfusion model induced by the permanent ligation of bilateral common carotid arteries (CCAs) in rats was employed in this study. Seven days after the ligation of bilateral CCAs, encephalo-myo-synangiosis (EMS) and plasmid administration in the temporal muscle were performed. Rats were divided into four groups by injected plasmids (i.e., LacZ group, VEGF group, apelin group, and VEGF/apelin group). Fourteen days after EMS, immunohistochemical analyses of cortical vessels were performed. Seven days after EMS, protein assays of cortex and attached muscle were performed. RESULTS: In the VEGF group and the VEGF/apelin group, the total number of blood vessels in the cortex was significantly larger than that in the LacZ group (p < 0.05, respectively). In the VEGF/apelin group, larger vessels were induced than in the other groups (p < 0.05, respectively). Apelin protein was not detected in the cortex of any groups. In the attached muscle apelin protein was detected only in the apelin group and the VEGF/apelin group. Immunohistochemical analysis revealed that apelin and its receptor APJ were expressed on the endothelial cells 7 days after the ligation of CCAs. CONCLUSIONS: The combined gene therapy of VEGF and apelin with EMS in a chronic cerebral hypoperfusion model in rats can enhance angiogenesis. This has potential as a feasible treatment option for moyamoya disease in a clinical setting. Background and Purpose Moyamoya disease (MMD) is a chronic, progressive cerebrovascular disease characterized by stenosis or occlusion of the bilateral supraclinoid internal cerebral arteries and the development of an abnormal vascular network called moyamoya vessels at the base of the brain that blocks cerebral flow.21 Indirect bypass surgeries such as enchepalo-myo-synangiosis (EMS) are mostly performed for pediatric patients with MMD. The critical issue in indirect bypass for MMD is the fact that the amount of collateral circulation by indirect bypass surgery is sometimes insufficient for most adult and some pediatric cases.20, 25, 27, 32, 39 To develop sufficient collateral circulation, we have investigated the effect of EMS combined with vascular endothelial growth factor (VEGF) gene administration to the temporal muscles in a chronic ischemia model in rats.15, 22 Adding the EMS surgery for bilateral common carotid arteries (CCAs) ligation, we have simulated the indirect bypass surgery for MMD. The data demonstrated that EMS with administration of plasmid human VEGF significantly increased angiogenesis in the cerebral cortex compared to EMS without administration of the VEGF gene.15, 22 The over-expression of VEGF can, however, introduce a risk of immature vessel formation that result in plasma leakage and angioma formation.4, 11, 24, 35 Apelin has been identified as the endogenous ligand of the orphan G protein-coupled receptor APJ that is expressed in the cardiovascular and central nervous systems.29 The apelin-APJ system is involved in a wide range of physiological activities, such as heart contractility and blood pressure regulation6, appetite and drinking behavior,23 neuroprotection,30 and angiogenesis.7, 14, 17, 18, 26 It has been reported that apelin together with VEGF effectively induced functional vessels that are larger than those with VEGF alone in the hind limb ischemia model.18 In this report, we evaluated whether the combined gene therapy of VEGF and apelin in indirect vasoreconstructive surgery enhances brain angiogenesis in a chronic cerebral hypoperfusion model in rats. Materials and Methods Animals and Surgical Procedures All animal procedures in this study were specifically approved by the Institutional Animal Care and Use Committee of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (approval number: OKU-2013158). Adult male Wistar rats (9-11 weeks old, weighing 250-350 g) were used for the experiments. Under general anesthesia with 2.0% halothane in a mixture of 40% oxygen and 60% nitrous oxide gas the common carotid arteries (CCAs) were carefully separated from the sympathetic and vagal nerves using a ventrocervical incision. Bilateral CCAs were ligated with 3-0 silk sutures. The body temperature in the rats was maintained close to 37°C throughout the procedure and by using a heating pad. Sham operations involved skin incision and exteriorization of bilateral CCAs without CCA ligation. An interval of 7 days was allowed for postoperative recovery (Figure 1A). Seven days after the bilateral CCAs ligation, the rats underwent EMS surgery (Figure 1B). The period between CCAs ligation and the EMS surgery is short, 7 days. This period was recruited because bilateral CCAs ligation reduces CBF to 35-50% of the control level, and CBF start to recover at 1 week. We thought that delayed EMS surgery after the beginning of CBF recover could be a negative effect for angiogenesis. In past literatures from other institutions, this period was recruited to develop similar model, too. Under the general anesthesia with the intraperitoneal administration of pentobarbital sodium (45mg/kg), the rats were placed in a stereotactic apparatus with the top of the skull positioned horizontally. After the midline linear incision, the right temporal muscle was detached from the temporal bone. Craniotomy was then performed in the temporo-parietal region using a dental drill. The dura mater was carefully opened and removed with no disruption of the brain surface (Figure 1C). The exposed brain surface was covered with the muscle flap (Figure 1D). Plasmid injection in the temporal muscle was performed using GenomOne-Neo transfection reagent (Ishihara Sangyo) according to the manufacturer’s protocol. Rats were divided into four groups by injected plasmids (i.e., LacZ group, VEGF group, apelin group, and VEGF/apelin group). Quantity of plasmid was 25μg in each group. In our previous report, we simply injected 50μg of VEGF plasmid into the temporal muscle, and found significant increase of capillary density.22 Moreover, we performed optimal dose analysis that demonstrated the maximal angiogenic effect occurred with a 100μg dose of VEGF plasmid.15 In comparison study of transfection efficacy between naked plasmid and method using GenomOne-Neo transfection reagent, transfection efficacy of this method was more than four times than injection of naked plasmid.38 Immunohistochemical Analysis Bilateral CCAs ligation and sham rats were euthanized with an overdose of pentobarbital (100mg/kg) 1 week after surgery (Figure 1A), and EMS model rats were euthanized 2 weeks after EMS (Figure 1B). They were perfused transcardially with 200 ml of cold phosphate-buffered saline (PBS) and 100 ml of 4% paraformaldehyde (PFA) in PBS. The brain and transfected temporal muscle were removed and post-fixed in the same fixative overnight at 4°C, and subsequently stored in 30% sucrose in PBS until completely submerged. Frozen coronal sections (17 μm thick) were cut from each specimen on a cryostat. The sections were thaw mounted on slides. Slides from the bilateral CCA ligation or sham operation without EMS surgery were evaluated with immunohistochemical analysis of endothelial cells (ECs) and apelin/APJ protein. Slides from the bilateral CCA ligation with EMS surgery 2 weeks after were evaluated with immunohistochemical analysis of ECs. The number per group was 8 in each group. Sections which include cortical surface were photographed at 10x magnification. The number of all vessels per field, percentage of vessel area per field and number of large vessels (>10 μm) per field were calculated in each photograph from the images using ImageJ. For the immunohistochemical staining of ECs, after several rinses in PBS, slides were incubated in 10% fetal bovine serum in PBS for 1 h. Then, the slides were washed and incubated with an affinity-purified mouse monoclonal anti-endothelial cell antibody (RECA-1) with 1% fetal bovine serum for 2 h at room temperature. The slides were washed and incubated for 1 h with a Cy3 anti-mouse IgG antibody at 1:200 dilution at room temperature. For the immunohistochemical staining of APJ and ECs, after several rinses in PBS, slides were incubated in 10% fetal bovine serum in PBS for 1 h. Then, the slides were washed and incubated with RECA-1 and an affinity-purified rabbit polyclonal anti-APJ antibody with 1% fetal bovine serum for 2 h at room temperature. The slides were washed and incubated for 1 h with a Cy3 anti-mouse IgG antibody at 1:200 dilution and Alexa fulor anti-rabbit IgG antibody at 1:200 at room temperature. For the immunohistochemical staining of apelin and ECs, after several rinses in PBS, slides were incubated in 10% normal goat serum in PBS for 1 h. Then, the slides were washed and incubated with an affinity-purified rabbit polyclonal anti-von Willebrand factor antibody and an affinity-purified mouse monoclonal anti-apelin antibody with 1% normal goat serum for 2 h at room temperature. The slides were washed and incubated for 1 h with an FITC anti-rabbit IgG antibody at a 1:300 dilution and a Cy3 anti-mouse IgG antibody at 1:300 dilution at room temperature. Enzyme-linked Immunosorbent Assay (ELISA) Analyses For protein assay, the CCAO and EMS models were quickly harvested after the decapitation of animals anesthetized with an overdose of pentobarbital (100 mg/kg, i.p.) 1 week after EMS surgery. The number per group was 2 in each group. Their brains and muscles were sliced with a thickness of 2mm. The brain tissue of the cortex was punched out using a biopsy punch (3 mm hole, Kai Corporation and Kai Industries Co., Ltd., Japan). Brain and muscle tissues were then homogenized in T-PER (Pierce, Rockford, IL) an

[1]  P. Vajkoczy,et al.  Myoblast-Mediated Gene Therapy Improves Functional Collateralization in Chronic Cerebral Hypoperfusion , 2015, Stroke.

[2]  O. Kim,et al.  The Role of VEGF and KDR Polymorphisms in Moyamoya Disease and Collateral Revascularization , 2012, PloS one.

[3]  P. Huh,et al.  Long-term follow-up results in 142 adult patients with moyamoya disease according to management modality , 2012, Acta Neurochirurgica.

[4]  G. Steinberg,et al.  Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article. , 2011, Journal of neurosurgery.

[5]  J. Kuratsu,et al.  Granulocyte Colony-Stimulating Factor Enhances the Angiogenetic Effect of Indirect Bypass Surgery for Chronic Cerebral Hypoperfusion in a Rat Model , 2011, Neurosurgery.

[6]  J. Y. Lee,et al.  Pediatric moyamoya disease: An analysis of 410 consecutive cases , 2010, Annals of neurology.

[7]  E. Connolly,et al.  Neurocognitive dysfunction in adult moyamoya disease , 2010, Journal of Neurology.

[8]  H. Kidoya,et al.  Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. , 2010, Blood.

[9]  N. Maulik,et al.  Coadministration of Adenoviral Vascular Endothelial Growth Factor and Angiopoietin-1 Enhances Vascularization and Reduces Ventricular Remodeling in the Infarcted Myocardium of Type 1 Diabetic Rats , 2009, Diabetes.

[10]  N. Saito,et al.  Experimental investigation of encephalomyosynangiosis using gyrencephalic brain of the miniature pig: histopathological evaluation of dynamic reconstruction of vessels for functional anastomosis. Laboratory investigation. , 2009, Journal of neurosurgery. Pediatrics.

[11]  K. Houkin,et al.  Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia , 2009, Experimental Neurology.

[12]  H. Kidoya,et al.  Maturation of blood vessels by haematopoietic stem cells and progenitor cells: Involvement of apelin/APJ and angiopoietin/Tie2 interactions in vessel caliber size regulation , 2009, Thrombosis and Haemostasis.

[13]  M. Fujiki,et al.  Induction of collateral circulation by hypoxia-inducible factor 1α decreased cerebral infarction in the rat , 2009, Neurological research.

[14]  S. Kuroda,et al.  Moyamoya disease: current concepts and future perspectives , 2008, The Lancet Neurology.

[15]  Hyung-Jin Lee,et al.  The neovascularization effect of bone marrow stromal cells in temporal muscle after encephalomyosynangiosis in chronic cerebral ischemic rats. , 2008, Journal of Korean Neurosurgical Society.

[16]  M. Eyries,et al.  Hypoxia-Induced Apelin Expression Regulates Endothelial Cell Proliferation and Regenerative Angiogenesis , 2008, Circulation research.

[17]  L. Dorfman,et al.  Effect of moyamoya disease on neuropsychological functioning in adults. , 2008, Neurosurgery.

[18]  N. Mochizuki,et al.  Spatial and temporal role of the apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis , 2008, The EMBO journal.

[19]  M. Dichter,et al.  Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury , 2007, Journal of neurochemistry.

[20]  F. Bari,et al.  Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseases , 2007, Brain Research Reviews.

[21]  W. Gao,et al.  Apelin increases contractility in failing cardiac muscle. , 2006, European journal of pharmacology.

[22]  J. Gutkind,et al.  VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin , 2006, Nature Cell Biology.

[23]  M. Aoki,et al.  Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes. , 2005, Journal of molecular and cellular cardiology.

[24]  S. Hinuma,et al.  Apelin is a novel angiogenic factor in retinal endothelial cells. , 2004, Biochemical and biophysical research communications.

[25]  M. Cornu,et al.  Apelin (65‐77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  H. Hamada,et al.  Pre‐administration of angiopoietin‐1 followed by VEGF induces functional and mature vascular formation in a rabbit ischemic model , 2003, The journal of gene medicine.

[27]  L. Zentilin,et al.  Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  M. Harrigan,et al.  Intraventricular Infusion of Vascular Endothelial Growth Factor Promotes Cerebral Angiogenesis with Minimal Brain Edema , 2002, Neurosurgery.

[29]  J. Chae,et al.  Coadministration of Angiopoietin-1 and Vascular Endothelial Growth Factor Enhances Collateral Vascularization , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[30]  H. Blau,et al.  VEGF gene delivery to myocardium: deleterious effects of unregulated expression. , 2000, Circulation.

[31]  M. Palkovits,et al.  Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. , 2000, Biochimica et biophysica acta.

[32]  J. Isner,et al.  Lower-Extremity Edema Associated with Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor , 2000, Annals of Internal Medicine.

[33]  L. Kedes,et al.  Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation. , 2000, Journal of the American College of Cardiology.

[34]  B. O'dowd,et al.  Characterization of Apelin, the Ligand for the APJ Receptor , 2000, Journal of neurochemistry.

[35]  J. Alexander,et al.  Vascular Permeability Factor/Vascular Endothelial Cell Growth Factor-mediated Permeability Occurs through Disorganization of Endothelial Junctional Proteins* , 1998, The Journal of Biological Chemistry.

[36]  T. Yoshimoto,et al.  Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients? , 1996, Surgical neurology.

[37]  H. Touho,et al.  Surgical reconstruction of failed indirect anastomosis in childhood Moyamoya disease. , 1993, Neurosurgery.

[38]  篤 勝間田 Optimal dose of plasmid vascular endothelial growth factor for enhancement of angiogenesis in the rat brain ischemia model , 2010 .

[39]  阿南 光洋 Induced angiogenesis under cerebral ischemia by cyclooxygenase 2 and hypoxia-inducible factor naked DNA in a rat indirect-bypass model , 2010 .

[40]  日下 昇 Enhanced brain angiogenesis in chronic cerebral hypoperfusion after administration of plasmid human vascular endothelial growth factor in combination with indirect vasoreconstructive surgery , 2007 .

[41]  田中健一 Relationship between cholinergic dysfunction and discrimination learning disabilities in Wistar rats following chronic cerebral hypoperfusion(脳血流慢性低灌流ラットにおけるコリン作動性神経機能低下と弁別学習障害の相関) , 1997 .